<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04880655</url>
  </required_header>
  <id_info>
    <org_study_id>20-07861-XP</org_study_id>
    <nct_id>NCT04880655</nct_id>
  </id_info>
  <brief_title>A Randomized Trial Evaluating EARLY Application of a Surfactant Dressing in Thermal Injury (EARLY)</brief_title>
  <acronym>EARLY</acronym>
  <official_title>A Randomized, Controlled Study Evaluating a Surfactant-based Wound Dressing for Tissue Salvage and Reduction in Surgical Burden</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Tennessee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medline Industries</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Tennessee</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the following hypotheses:&#xD;
&#xD;
        1. Early use of water-soluble surfactant dressing (WSD) on partial-thickness burn wounds&#xD;
           will result in tissue salvage and reduce surgical burden.&#xD;
&#xD;
        2. Early use of WSD on partial-thickness burn wounds will result in faster healing.&#xD;
&#xD;
        3. Use of WSD on partial-thickness burn wounds will result in less painful wound care.&#xD;
&#xD;
        4. Early use of WSD on partial-thickness burn wounds will result in less infection.&#xD;
&#xD;
        5. Early use of WSD on partial-thickness burn wounds will result in lower hospital costs.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Surfactant-based wound dressings have been utilized in chronic, non-healing wounds and small&#xD;
      burn wounds to soften and aid removal of wound debris. In vitro data suggest enhanced healing&#xD;
      properties are due the ability to stabilize and potentially reseal plasma membranes, thereby,&#xD;
      retaining cellular integrity and enhance wound healing. Improved cellular viability and&#xD;
      functionality has also been established in heat-shock, ionizing radiation, and electrical&#xD;
      injury models. In one rat model, topically suffused mesentery demonstrated improved&#xD;
      microvascular flow and reduction in the number of abnormally flowing microvessels following&#xD;
      thermal injury. Intravenous administration has been studied in several disease states. In&#xD;
      thermal injury, intravenous administration has shown potential to improve blood flow and&#xD;
      reduce the zone of coagulation. Further, surfactant-based wound dressings are non-ionic and&#xD;
      may facilitate removal, sensitize, or prevent bacterial biofilms. Biofilms are an evolved,&#xD;
      protective mechanism bacteria utilize to reduce antimicrobial efficacy. Removal or&#xD;
      penetration of biofilms is essential for bacterial eradication. There is little evidence&#xD;
      demonstrating the efficacy of early use of a WSD for treating partial-thickness burn wounds.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2021</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent difference (cm2) in partial-thickness wound conversion</measure>
    <time_frame>Up to 14 days</time_frame>
    <description>Tissue salvage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to 95% re-epithelialization</measure>
    <time_frame>Up to 28 days</time_frame>
    <description>Healing time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily pain scores for each wound care session</measure>
    <time_frame>Up to 7 days</time_frame>
    <description>Pain via Numeric Rating Scale (0-10; 0 having no pain and 10 being the worst possible pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of burn wound infection and cellulitis</measure>
    <time_frame>Up to 28 days</time_frame>
    <description>Infection up to day of initial excision or day of discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital costs</measure>
    <time_frame>Up to 28 days</time_frame>
    <description>Cost of care during inpatient stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Burns</condition>
  <condition>Partial-thickness Burn</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dressed with WSD and petrolatum gauze</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dressed with bacitracin and petrolatum gauze</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WSD</intervention_name>
    <description>Post debridement and within 24 hours of injury, wound care and WSD applied daily</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dressed with bacitracin and petrolatum gauze</intervention_name>
    <description>Post debridement and within 24 hours of injury, wound care and dressing applied daily</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age ≥ 18 years old&#xD;
&#xD;
          -  admitted within 24 hours of injury&#xD;
&#xD;
          -  partial-thickness burn wounds on at least two non-contiguous areas of &lt; 10% TBSA each&#xD;
             and not involving face, fingers, toes, and perineum&#xD;
&#xD;
          -  initial management assessed to require inpatient care&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  chemical, electrical, or inhalation injury&#xD;
&#xD;
          -  pregnant&#xD;
&#xD;
          -  incarcerated&#xD;
&#xD;
          -  TBSA ≥ 20%&#xD;
&#xD;
          -  wound expected to heal within 7 days&#xD;
&#xD;
          -  patient or authorized representative unable or unwilling to consent&#xD;
&#xD;
          -  unable to consent within 24 hours of injury&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yvonne Shaw, RN</last_name>
    <phone>901-448-2714</phone>
    <email>yshaw@uthsc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>David M. Hill, PharmD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Regional One Health</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38103</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Yvonne Shaw, RN</last_name>
      <email>yshaw@uthsc.edu</email>
    </contact>
    <investigator>
      <last_name>David M. Hill, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>S. Ram Velamuri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kalyan Dadireddy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Palumbo FP, Harding KG, Abbritti F, Bradbury S, Cech JD, Ivins N, Klein D, Menzinger G, Meuleneire F, Seratoni S, Zölß C, Mayer D. New Surfactant-based Dressing Product to Improve Wound Closure Rates of Nonhealing Wounds: A European Multicenter Study Including 1036 Patients. Wounds. 2016 Jul;28(7):233-40.</citation>
    <PMID>27428718</PMID>
  </reference>
  <reference>
    <citation>Birchenough SA, Rodeheaver GT, Morgan RF, Peirce SM, Katz AJ. Topical poloxamer-188 improves blood flow following thermal injury in rat mesenteric microvasculature. Ann Plast Surg. 2008 May;60(5):584-8. doi: 10.1097/SAP.0b013e3181651661.</citation>
    <PMID>18434836</PMID>
  </reference>
  <reference>
    <citation>Rodeheaver GT, Kurtz L, Kircher BJ, Edlich RF. Pluronic F-68: a promising new skin wound cleanser. Ann Emerg Med. 1980 Nov;9(11):572-6.</citation>
    <PMID>7436067</PMID>
  </reference>
  <reference>
    <citation>Chen R, Salisbury AM, Percival SL. In vitro cellular viability studies on a concentrated surfactant-based wound dressing. Int Wound J. 2019 Jun;16(3):703-712. doi: 10.1111/iwj.13084. Epub 2019 Mar 20.</citation>
    <PMID>30895731</PMID>
  </reference>
  <reference>
    <citation>Maskarinec SA, Wu G, Lee KY. Membrane sealing by polymers. Ann N Y Acad Sci. 2005 Dec;1066:310-20. Review.</citation>
    <PMID>16533934</PMID>
  </reference>
  <reference>
    <citation>Lee RC, Hannig J, Matthews KL, Myerov A, Chen CT. Pharmaceutical therapies for sealing of permeabilized cell membranes in electrical injuries. Ann N Y Acad Sci. 1999 Oct 30;888:266-73.</citation>
    <PMID>10842638</PMID>
  </reference>
  <reference>
    <citation>Lee RC, River LP, Pan FS, Ji L, Wollmann RL. Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo. Proc Natl Acad Sci U S A. 1992 May 15;89(10):4524-8.</citation>
    <PMID>1584787</PMID>
  </reference>
  <reference>
    <citation>Walsh AM, Mustafi D, Makinen MW, Lee RC. A surfactant copolymer facilitates functional recovery of heat-denatured lysozyme. Ann N Y Acad Sci. 2005 Dec;1066:321-7.</citation>
    <PMID>16533935</PMID>
  </reference>
  <reference>
    <citation>Greenebaum B, Blossfield K, Hannig J, Carrillo CS, Beckett MA, Weichselbaum RR, Lee RC. Poloxamer 188 prevents acute necrosis of adult skeletal muscle cells following high-dose irradiation. Burns. 2004 Sep;30(6):539-47.</citation>
    <PMID>15302418</PMID>
  </reference>
  <reference>
    <citation>Baskaran H, Toner M, Yarmush ML, Berthiaume F. Poloxamer-188 improves capillary blood flow and tissue viability in a cutaneous burn wound. J Surg Res. 2001 Nov;101(1):56-61.</citation>
    <PMID>11676555</PMID>
  </reference>
  <reference>
    <citation>Yang Q, Schultz GS, Gibson DJ. A Surfactant-Based Dressing to Treat and Prevent Acinetobacter baumannii Biofilms. J Burn Care Res. 2018 Aug 17;39(5):766-770. doi: 10.1093/jbcr/irx041.</citation>
    <PMID>29931339</PMID>
  </reference>
  <reference>
    <citation>Yang Q, Larose C, Della Porta AC, Schultz GS, Gibson DJ. A surfactant-based wound dressing can reduce bacterial biofilms in a porcine skin explant model. Int Wound J. 2017 Apr;14(2):408-413. doi: 10.1111/iwj.12619. Epub 2016 May 22.</citation>
    <PMID>27212453</PMID>
  </reference>
  <reference>
    <citation>Salisbury AM, Percival SL. Efficacy of a Surfactant-Based Wound Dressing in the Prevention of Biofilms. Adv Skin Wound Care. 2018 Nov;31(11):514-520. doi: 10.1097/01.ASW.0000544612.28804.34.</citation>
    <PMID>30335643</PMID>
  </reference>
  <reference>
    <citation>Mayer D, Armstrong D, Schultz G, Percival S, Malone M, Romanelli M, Keast D, Jeffery S. Cell salvage in acute and chronic wounds: a potential treatment strategy. Experimental data and early clinical results. J Wound Care. 2018 Sep 2;27(9):594-605. doi: 10.12968/jowc.2018.27.9.594.</citation>
    <PMID>30204575</PMID>
  </reference>
  <reference>
    <citation>Pittinger TP, Curran D, Hermans MH. The treatment of paediatric burns with concentrated surfactant gel technology: a case series. J Wound Care. 2020 Jun 1;29(Sup6):S12-S17. doi: 10.12968/jowc.2020.29.Sup6.S12.</citation>
    <PMID>32530755</PMID>
  </reference>
  <reference>
    <citation>Pittinger T, Curran D, Hermans M. Treatment of Burns in Adult Patients With a Concentrated Surfactant Gel: A Real-life Retrospective Evaluation. Wounds. 2020 Dec;32(12):339-344.</citation>
    <PMID>33472159</PMID>
  </reference>
  <reference>
    <citation>Kirsner RS, Amaya R, Bass K, Boyar V, Ciprandi G, Glat PM, Percival SL, Romanelli M, Pittinger TP. Effects of a surfactant-based gel on acute and chronic paediatric wounds: a panel discussion and case series. J Wound Care. 2019 Jun 2;28(6):398-408. doi: 10.12968/jowc.2019.28.6.398.</citation>
    <PMID>31166855</PMID>
  </reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>May 3, 2021</study_first_submitted>
  <study_first_submitted_qc>May 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2021</study_first_posted>
  <last_update_submitted>May 8, 2021</last_update_submitted>
  <last_update_submitted_qc>May 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>EARLY</keyword>
  <keyword>Randomized Clinical Trial</keyword>
  <keyword>Surfactant</keyword>
  <keyword>Dressing</keyword>
  <keyword>Total Body Surface Area</keyword>
  <keyword>Outcome Assessment</keyword>
  <keyword>Thermal Burn Injuries</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacitracin</mesh_term>
    <mesh_term>Petrolatum</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

